论文部分内容阅读
目的:探讨经肛门改良Soave术和经腹治疗先天性巨结肠的临床疗效。方法:对大于3岁的41例患儿(经肛门改良Soave术治疗28例,经腹治疗24例,在术后并发症和排便功能等方面进行回顾性对比分析。结果:并发症的总发生率经肛门改良Soave术明显少于经腹,HAEC发生率低于经腹组,有统计学意义。总的排便控制和大便形态方面经肛门改良Soave术优于经腹。结论:经肛门改良Soave术治疗先天性巨结肠方法可行、安全,效果优于经腹,但是术后仍有诸多并发症,特别在排便控制方面,仍需大量的病例进行长期的随访研究评估。
Objective: To investigate the clinical effect of modified anastomosis Soave and abdomen treatment of Hirschsprung’s disease. Methods: A total of 41 children older than 3 years old were treated with Soave anal anastomosis in 28 cases and 24 cases underwent abdominal surgery. The postoperative complications and defecation function were compared retrospectively.Results: The total complication rate Rate of anal revascularization was significantly less than that of Soave in transabdominal, and the incidence of HAEC was lower than that of transabdominal group. The total defecation control and defecation morphology were superior to transabdominal in the anastomosis soave.Conclusion: The treatment of Hirschsprung’s disease is feasible, safe and effective, but there are still many complications after the operation. Especially in the control of defecation, a large number of cases are still needed for long-term follow-up study evaluation.